The major mechanisms by which β-cells generate hyperinsulinemia during adaptive compensation consist of functional (e.g., increased insulin biosynthesis and/or secretion) and structural adaptations (e.g., increased β-cell hyperplasia and hypertrophy that may result in increased β-cell mass) [14–16]. The gene discussed is INS; the disease is hyperinsulinism.